This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignees: Abbvie Deutschland Gmbh and Co Kg, Abbvie Inc.. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 167 
1 out of 826 
Years Active: 2013
Title: Kenneth B. Gordon: Innovator in Psoriasis Treatment
Introduction
Kenneth B. Gordon is a notable inventor based in Northbrook, IL (US), recognized for his contributions to medical science, particularly in the treatment of psoriasis. His innovative approach has led to the development of a unique method that utilizes antibodies to target specific subunits involved in the disease.
Latest Patents
Gordon holds 1 patent for his invention titled "Methods for treating psoriasis using antibodies that bind to the P40 subunit of IL-12 and/or IL-23." This patent outlines methods for treating psoriasis by administering an antibody capable of binding to the p40 subunit of IL-12 and/or IL-23, providing a promising avenue for effective treatment.
Career Highlights
Throughout his career, Kenneth B. Gordon has worked with prominent companies in the pharmaceutical industry, including AbbVie Inc. and Abb Vie Deutschland GmbH & Co. KG. His experience in these organizations has significantly contributed to his expertise in developing innovative treatments.
Collaborations
Gordon has collaborated with esteemed colleagues such as Joaquin Mario Valdes and Elliot Keith Chartash, further enhancing the impact of his work in the field of psoriasis treatment.
Conclusion
Kenneth B. Gordon's innovative methods for treating psoriasis highlight his significant contributions to medical science. His work continues to inspire advancements in the treatment of this challenging condition.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile